Press Releases

Month Year

Get News Alerts by Email

Apr 26, 2022

Long-term Health Outcomes Using Simulation Model of Investigational Lecanemab in Patients with Early Alzheimer's Disease Published in a Peer-Reviewed Journal, Neurology and Therapy

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") today announced an article about long-term health outcomes of its investigational anti-amyloid-beta (Aβ) protofibril antibody...
Apr 7, 2022

Eisai Statement on The Centers For Medicare And Medicaid Services’ National Coverage Determination with Coverage with Evidence Development for Monoclonal Antibodies Directed Against Amyloid for the Treatment Of Alzheimer’s Disease

Eisai stands with people living with Alzheimer’s disease (AD), health care professionals and other members of our AD community. We respect that the Centers for Medicare and Medicaid Services...
Apr 4, 2022

Geisinger, Eisai team up to study use of artificial intelligence for early detection and identification of cognitive impairment that could indicate dementias, including Alzheimer's disease

Research collaboration will test novel algorithm's effectiveness on Geisinger data DANVILLE, Pa. and NUTLEY, N.J., April 4, 2022 /PRNewswire/ -- Geisinger and Eisai Inc. today announced a...
Mar 31, 2022

Eisai to Present Data on Neurology Portfolio in the Areas of Alzheimer's Disease, Sleep and Epilepsy at the 74th American Academy of Neurology® (AAN) Annual Meeting

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today the company will present research from its robust neurology portfolio, including the findings on lecanemab, an...
Mar 30, 2022

Meagan Good Shares Her Scare with Uterine Cancer to Encourage People to Spot the Early Signs of Endometrial Cancer as Part of Eisai and Advocacy Partners' Spot Her® Campaign

Spot Her Aims to Educate People About the Signs and Risk Factors of Endometrial Cancer, One of the Most Common Yet Under-Recognized Women's Cancers Actor Leads Spot Her Virtual Walk to Increase...
- Photos 2

Show per page

Open a printable version of this page
Email the URL of this page to a friend

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa